Sulbactam sodium structure
|
Common Name | Sulbactam sodium | ||
---|---|---|---|---|
CAS Number | 69388-84-7 | Molecular Weight | 255.223 | |
Density | N/A | Boiling Point | 567.7ºC at 760 mmHg | |
Molecular Formula | C8H10NNaO5S | Melting Point | 121-123 °C(lit.) | |
MSDS | N/A | Flash Point | 297.1ºC |
Use of Sulbactam sodiumSulbactam (CP45899) sodium is a competitive, irreversible beta-lactamase inhibitor. Sulbactam sodium shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2]. |
Name | Sulbactam sodium |
---|---|
Synonym | More Synonyms |
Description | Sulbactam (CP45899) sodium is a competitive, irreversible beta-lactamase inhibitor. Sulbactam sodium shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2]. |
---|---|
Related Catalog | |
In Vitro | Ampicillin-Sulbactam has a wide range of antibacterial activity that includes Gram-positive and Gram-negative aerobic and anaerobic bacteria[3]. |
References |
[1]. Noguchi JK, et al. Sulbactam: a beta-lactamase inhibitor. Clin Pharm. 1988;7(1):37-51. |
Boiling Point | 567.7ºC at 760 mmHg |
---|---|
Melting Point | 121-123 °C(lit.) |
Molecular Formula | C8H10NNaO5S |
Molecular Weight | 255.223 |
Flash Point | 297.1ºC |
Exact Mass | 255.017731 |
PSA | 102.96000 |
Storage condition | -20°C Freezer, Under Inert Atmosphere |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | R42/43 |
Safety Phrases | S26-S37/39 |
WGK Germany | 3 |
HS Code | 2941109900 |
~92% Sulbactam sodium CAS#:69388-84-7 |
Literature: SANDOZ AG Patent: WO2009/53256 A2, 2009 ; Location in patent: Example 1 ; |
~77% Sulbactam sodium CAS#:69388-84-7 |
Literature: Leo Pharmaceutical Products Ltd. A/S Patent: US4816580 A1, 1989 ; |
HS Code | 2941109900 |
---|
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Curr. Med. Res. Opin. 29(7) , 869-77, (2013) The FDA recently issued guidance for the types of infections that should be included in trials to support an indication for antibacterial treatment. The latest FDA guidance recommends assessing respon... |
|
Antibiotic regimens for management of intra-amniotic infection.
Cochrane Database Syst. Rev. 12 , CD010976, (2014) Chorioamnionitis is a common infection that affects both mother and infant. Infant complications associated with chorioamnionitis include early neonatal sepsis, pneumonia, and meningitis. Chorioamnion... |
|
Anaerobiospirillum succiniciproducens-induced bacteremia in a healthy man.
Am. J. Emerg. Med. 32(7) , 812.e1-3, (2014) Anaerobiospirillum succiniciproducens is rarely associated with bacteremia but results in significant mortality. Almost all reported bacteremia cases have occurred in immunocompromised hosts, such as ... |
SULBACTAM SODIUM SALT |
sodium Penicillanate 1,1-Dioxide |
SulbactaM SodiuM,USP |
sulbacyam sodium |
penicillanic acid 1,1-dioxide sodium salt |
SODIUM SULBACTAM |
EINECS 273-984-4 |
Sulbatam Sodium |
SulbactaM SodiuM API |
MFCD01750374 |